venBio biotechnology firm tweaks top ranks as flagship soars 50.3% in 2014

By Simone Foxman

Thu Aug 7, 2014


Two years of outperformance push firm assets to $335 million.


Biotech-focused venBio Select Advisor is off to another jaw-dropping year and has been formalizing its infrastructure to accommodate rapid growth. The now-$335 million firm has hired a chief financial and compliance officer, and it put a sole portfolio manager in charge of the high-flying flagship hedge fund.

That hedge fund, the venBio Select Fund, generated a return of 50.3% through July, according to a July 31 investor letter. That compares with a rise of 4.50% for the Absolute Return Global Equity Index. The fund’s assets have more than tripled in that time period, from $44 million at yearend 2013, to $137 million as of July 31 (firmwide assets of $335 million also include a separate private equity fund). The hedge fund began 2013 with less than $20 million and went on to return 122.43%....

ISSN: 2151-1845 / CDC10004H

Register

By registering you will receive

  • A monthly newsletter on your specified areas of interest
  • A fortnightly update on the sector

Free Trial

Take a trial today and access

  • Performance news, fund launches, regulation changes and people moves
  • Profiles of fund managers, investors and distributors
  • Live league tables
  • Investor mandates


Popular Searches on HFI